Suivre
Silvia Sequero
Silvia Sequero
Department of Oncology, San Cecilio University Hospital, Granada (Spain)
Adresse e-mail validée de juntadeandalucia.es
Titre
Citée par
Citée par
Année
Influence of CYP2D6 polymorphism in the outcome of breast cancer patients undergoing tamoxifen adjuvant treatment.
I Blancas, CJ Rodriguez Gonzalez, AJ Munoz-Serrano, MT Delgado, ...
Journal of Clinical Oncology 36 (15_suppl), e12521-e12521, 2018
32018
Long‐term follow‐up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group
B Núñez‐García, M Rodríguez‐Pertierra, S Sequero, LG Carvajal, ...
Hematological Oncology 39 (4), 506-512, 2021
12021
Evaluation of the conversion rate in Ki-67, estrogen receptor (ER), progesterone receptor (PR) and HER2 between primary breast cancer and relapse and their value as a …
IB López-Barajas, A Muñoz, M Legerén, F Galvez, R González, JM Jurado, ...
Annals of Oncology 27, vi31, 2016
12016
Monitoring of circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study.
I Fernández-Miranda, L Pedrosa, M Llanos, FF Franco, S Gómez, ...
Clinical Cancer Research: an Official Journal of the American Association …, 2022
2022
Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the ATEZOBLADDERPRESERVE phase II trial …
S Vazquez-Estevez, O Fernandez-Calvo, T Bonfill-Abella, S Sequero, ...
Journal of Clinical Oncology 40 (16_suppl), 4588-4588, 2022
2022
Prospective evaluation of the prognostic value of circulating tumor DNA in patients with follicular lymphoma: A pilot study.
I Fernández-Miranda, A K Ballesteros, M Llanos, F Franco, ...
Journal of Clinical Oncology 40 (16_suppl), 7569-7569, 2022
2022
A GENE SIGNATURE TO PREDICT RISK OF TRANSFORMATION IN PATIENTS WITH FOLLICULAR LYMPHOMA
Hematological Oncology 39 (S2), 2021
2021
889MO Long-term follow-up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group
BN Garcia, M Rodríguez-Pertierra, S Sequero, D Aguiar, LG Carvajal, ...
Annals of Oncology 31, S650, 2020
2020
Optimizing management of the oncological patient with pulmonary embolism: Validation of the epiphany index—PERSEO study.
M Sanchez Canovas, M Cejuela Solís, I De la Haba Vacas, D Gomez, ...
Journal of Clinical Oncology 38 (15_suppl), 12085-12085, 2020
2020
Usefulness of NT-ProBNP as a biomarker of cardiotoxicity in breast cancer patients treated with trastuzumab
I Blancas, C Martín, FJ Martín-Pérez, M Legerén, M Martos, S Sequero, ...
Annals of Oncology 30, v72-v73, 2019
2019
Effect of HER2/neu 655 polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients.
I Blancas, C Martín, M Legerén, M Martos, S Sequero, N Mut-Salud, ...
Journal of Clinical Oncology 37 (15_suppl), 1025-1025, 2019
2019
P3. 17-16 Adenocarcinoma or Epidermoid? The Importance of the Histological Subdivision
S Sequero, J Jurado-Garcia, M Perez-Garcia, D Castillo-Barnes
Journal of Thoracic Oncology 13 (10), S1026, 2018
2018
Adenocarcinoma or Epidermoid? The Importance of the Histological Subdivision: P3. 17-16
S Sequero, J Jurado-Garcia, M Perez-Garcia, D Castillo-Barnes
Journal of Thoracic Oncology 13 (10), 2018
2018
Stage III: Analysis to Assist in the Decision of Surgery Against Quimio-Radiotherapy: P3. 17-17
S Sequero, J Jurado-Garcia, M Perez-Garcia, D Castillo-Barnes
Journal of Thoracic Oncology 13 (10), 2018
2018
P3. 17-17 Stage III: Analysis to Assist in the Decision of Surgery Against Quimio-Radiotherapy
S Sequero, J Jurado-Garcia, M Perez-Garcia, D Castillo-Barnes
Journal of Thoracic Oncology 13 (10), S1027, 2018
2018
Long‐Term Follow‐Up of Patients with Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Report from the Spanish Lymphoma Oncology Group
BN García, M Rodríguez‐Pertierra, S Sequero, LG Carvajal, ...
Hematological Oncology, 0
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–16